Published in J Am Heart Assoc on February 23, 2015
Ventricular repolarization measures for arrhythmic risk stratification. World J Cardiol (2016) 0.76
Patients reasons for obtaining psychotropic medications without a prescription at retail pharmacies in Central Saudi Arabia. Neurosciences (Riyadh) (2016) 0.75
Complete Recovery from Cardiac Arrest Caused by Risperidone-induced Hypothermia. Innov Clin Neurosci (2016) 0.75
Drug-related mortality among inpatients: a retrospective observational study. Eur J Clin Pharmacol (2016) 0.75
Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study. Sci Rep (2017) 0.75
Psychotropic medications and the risk of sudden cardiac death. J Am Heart Assoc (2015) 0.75
Development and Validation of a GC-MS Method for the Detection and Quantification of Clotiapine in Blood and Urine Specimens and Application to a Postmortem Case. Int J Anal Chem (2015) 0.75
Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias. Curr Cardiol Rev (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol (1991) 12.76
Drug-induced prolongation of the QT interval. N Engl J Med (2004) 10.96
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Sudden cardiac death in the United States, 1989 to 1998. Circulation (2001) 7.92
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89
Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry (2001) 5.16
Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04
Drug induced QT prolongation and torsades de pointes. Heart (2003) 3.97
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry (2010) 2.57
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol (2011) 2.15
Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs (2002) 2.09
Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J (2011) 1.99
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Antipsychotics and the risk of sudden cardiac death. Arch Intern Med (2004) 1.78
Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs (2011) 1.39
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf (2013) 1.24
Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med (2005) 1.22
Schizophrenia and sudden cardiac death: a review. Nord J Psychiatry (2008) 1.19
Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf (2001) 1.15
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One (2013) 1.13
Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol (2009) 1.08
Genome-wide association study of antipsychotic-induced QTc interval prolongation. Pharmacogenomics J (2010) 1.04
Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death. Heart (2010) 1.01
A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. Pharmacoepidemiol Drug Saf (2012) 1.00
Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol (2007) 0.95
Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database. Cardiovasc Psychiatry Neurol (2013) 0.88
QTc prolongation with antipsychotics: is routine ECG monitoring recommended? J Psychiatr Pract (2014) 0.87
Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States. J Clin Exp Cardiolog (2013) 0.85
Association between antidepressants and venous thromboembolism in Taiwan. J Clin Psychopharmacol (2013) 0.82
Risk of serious cardiac events in older adults using antipsychotic agents. Am J Geriatr Pharmacother (2011) 0.80
Evidence for a crucial modulating role of the sodium channel in the QTc prolongation related to antipsychotics. J Psychopharmacol (2013) 0.79